Great Lakes Advisors LLC Sells 80,971 Shares of Masimo Corporation $MASI

Great Lakes Advisors LLC trimmed its holdings in shares of Masimo Corporation (NASDAQ:MASI) by 98.3% in the third quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The institutional investor owned 1,377 shares of the medical equipment provider’s stock after selling 80,971 shares during the period. Great Lakes Advisors LLC’s holdings in Masimo were worth $203,000 as of its most recent SEC filing.

Other institutional investors and hedge funds also recently bought and sold shares of the company. Massachusetts Financial Services Co. MA increased its stake in shares of Masimo by 6.1% in the third quarter. Massachusetts Financial Services Co. MA now owns 2,619,960 shares of the medical equipment provider’s stock valued at $386,575,000 after buying an additional 149,567 shares in the last quarter. State Street Corp increased its position in Masimo by 0.7% in the 2nd quarter. State Street Corp now owns 1,486,394 shares of the medical equipment provider’s stock valued at $250,041,000 after acquiring an additional 10,403 shares in the last quarter. Westfield Capital Management Co. LP raised its stake in shares of Masimo by 75.9% in the second quarter. Westfield Capital Management Co. LP now owns 1,181,203 shares of the medical equipment provider’s stock worth $198,702,000 after acquiring an additional 509,724 shares during the last quarter. Durable Capital Partners LP lifted its position in shares of Masimo by 3.4% during the second quarter. Durable Capital Partners LP now owns 1,163,898 shares of the medical equipment provider’s stock worth $195,791,000 after purchasing an additional 38,279 shares in the last quarter. Finally, Geode Capital Management LLC grew its stake in shares of Masimo by 6.2% during the second quarter. Geode Capital Management LLC now owns 896,418 shares of the medical equipment provider’s stock valued at $150,817,000 after purchasing an additional 52,100 shares during the last quarter. Institutional investors and hedge funds own 85.96% of the company’s stock.

Masimo Trading Up 0.8%

Shares of NASDAQ MASI opened at $138.42 on Tuesday. Masimo Corporation has a twelve month low of $125.94 and a twelve month high of $194.88. The stock has a market cap of $7.43 billion, a price-to-earnings ratio of -13.13, a P/E/G ratio of 1.39 and a beta of 1.26. The company has a quick ratio of 1.92, a current ratio of 2.84 and a debt-to-equity ratio of 0.69. The company’s fifty day moving average is $137.85 and its 200-day moving average is $144.17.

Masimo (NASDAQ:MASI) last posted its earnings results on Tuesday, November 4th. The medical equipment provider reported $1.32 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.12. Masimo had a positive return on equity of 33.04% and a negative net margin of 33.20%.The firm had revenue of $371.20 million for the quarter, compared to analyst estimates of $366.89 million. During the same period in the previous year, the company posted $0.86 earnings per share. The company’s revenue for the quarter was up 8.2% on a year-over-year basis. Equities research analysts predict that Masimo Corporation will post 4.1 EPS for the current year.

Analysts Set New Price Targets

MASI has been the subject of several research analyst reports. Zacks Research cut shares of Masimo from a “strong-buy” rating to a “hold” rating in a research report on Friday, October 24th. Weiss Ratings restated a “sell (d)” rating on shares of Masimo in a research report on Thursday, January 22nd. Wells Fargo & Company reiterated an “overweight” rating and issued a $190.00 price target on shares of Masimo in a report on Friday, December 5th. Wall Street Zen upgraded Masimo from a “hold” rating to a “buy” rating in a research report on Tuesday, October 14th. Finally, BTIG Research upped their target price on shares of Masimo from $198.00 to $200.00 and gave the company a “buy” rating in a research report on Thursday, December 4th. Four analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the company’s stock. According to MarketBeat, the stock presently has a consensus rating of “Hold” and a consensus price target of $189.40.

About Masimo

Masimo (NASDAQ: MASI) is a global medical technology company specializing in noninvasive monitoring solutions. The company’s flagship technology, Masimo SET® (Signal Extraction Technology), enhances the accuracy of pulse oximetry in challenging clinical conditions. Beyond pulse oximetry, Masimo’s portfolio extends to brain function monitoring, regional oximetry, and acoustic respiration rate monitoring, serving critical, acute, and ambulatory care settings.

In addition to its core monitoring technologies, Masimo offers a range of patient cables, sensors, and connectivity platforms designed to integrate with hospital information systems and remote monitoring applications.